Business Context and Reporting Period
Company: Forum Energy Technologies, Inc. (FET)
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2024
Reporting Period: The filing provides unaudited pro forma condensed combined financial statements as of and for the year ended December 31, 2023.
The report details the completion of the acquisition of all issued and outstanding common shares of Variperm Holdings Ltd. ("Variperm") by Forum Canada ULC, a wholly-owned subsidiary of Forum. The transaction was consummated on January 4, 2024, pursuant to a Stock Purchase Agreement dated November 1, 2023.
Key Financial Metrics
The filing incorporates pro forma financial statements giving effect to the Variperm acquisition. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached Exhibit 99.1 (Unaudited pro forma condensed combined financial statements), which is referenced but not included in the provided text.
Material Changes
- Acquisition Completion: Variperm became a wholly-owned subsidiary of Forum Canada ULC on January 4, 2024.
- Pro Forma Adjustments: Financial statements for the year ended December 31, 2023, have been adjusted to reflect the acquisition as if it had occurred at the beginning of the period.
Guidance, Outlook, and Other Events
- Registration Statement: Forum intends to file a Registration Statement on Form S-3 to register 1,946,038 shares of common stock ($0.01 par value) to be offered by selling stockholders identified in that statement.
- Management Commentary: The filing does not contain specific management commentary, forward-looking guidance, or risk factors beyond the standard incorporation of the pro forma statements and the description of the acquisition.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific pro forma revenue, net income, and debt figures resulting from the Variperm acquisition.
- Verify the terms of the Stock Purchase Agreement dated November 1, 2023, to understand the purchase price and any contingent consideration.
- Monitor the upcoming Form S-3 filing to identify the selling stockholders and the potential dilution impact of the 1,946,038 shares being registered.
- Assess the integration risks and synergies associated with combining Variperm's operations with Forum's existing business.